Genprex presents diabetes gene therapy delivery strategy at symposium
GNPX•Genprex will present its dual-delivery diabetes gene therapy strategy at the virtual Future of Cell and Gene Therapy Symposium on Nov. 17-18, 2026.
1. Symposium presentation
Genprex will present its diabetes gene therapy delivery strategy at the virtual Future of Cell and Gene Therapy Symposium on Nov. 17-18, 2026. Pier-Anne Lachance, senior director of quality control and product development, will discuss AAV-based and nonviral lipid-based approaches, both in preclinical development.
